{"id":798092,"date":"2025-01-06T11:42:30","date_gmt":"2025-01-06T16:42:30","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/"},"modified":"2025-01-06T11:42:30","modified_gmt":"2025-01-06T16:42:30","slug":"shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/","title":{"rendered":"SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ATLANTA, Jan.  06, 2025  (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Revance Therapeutics, Inc. (\u201cRevance\u201d or the \u201cCompany\u201d) (NASDAQ: RVNC). The lawsuit alleges that Defendants made materially false and\/or misleading statements, and\/or failed to disclose material adverse facts about Revance\u2019s business, operations, and prospects, including allegations that: (i) Revance was in material breach of its distribution agreement with Teoxane SA; (ii) the foregoing subjected Revance to an increased risk of litigation, as well as monetary and reputational harm; and (iii) all the foregoing increased the risk that Crown Laboratories, Inc.\u2019s tender offer to acquire all outstanding shares of the Company\u2019s common stock would be delayed and\/or amended.<\/p>\n<p align=\"justify\">If you bought shares of Revance between <strong>February 29, 2024 and December 6, 2024<\/strong>, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ULmCECCELNELyE3LrVdAbhqQ1jhBh1ob3J0L6SVlydttLcCNDYabKK8EBdrfMmykjfJCkR28xcIYxpXj17LcPcIHnMLEKCjpw7W4ZvaFgl0=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=X7WNC91VYzxQNhpyOpyTYLDQtbJG9AqaTwj3Ls_MqTFT6-E-7j1YztrxM343quTO8G2N-xehEEvU3ayFKE-N4CzI92b0LBc3VRma9O85PWor1DBxZwAPTQe-BJhBhlLWqoineTwzAMB2lu9w5zBOlBQFTAMhlAsgfxe8G1xP07s=\" rel=\"nofollow\" target=\"_blank\"><u>www.holzerlaw.com\/case\/revance-therapeutics\/<\/u><\/a> to learn more.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is March 4, 2025.<\/strong>\n      <\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website,\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=X7WNC91VYzxQNhpyOpyTYA60-_7YQumc3XNTqLJmb9UvPg-PvQqMufy08efTL-xH2WS5ZPTgASM0kvnYdhCOxM5uc8bzB8b1gxD7mzuyJFo=\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com<\/a>,\u202fand upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.\u202f\u00a0<\/p>\n<p align=\"justify\">CONTACT:<br \/>Corey Holzer, Esq.<br \/>(888) 508-6832 (toll-free) <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ULmCECCELNELyE3LrVdAbhqQ1jhBh1ob3J0L6SVlydtokLLUbZjjOycxRCg2NIis6nKR2KqDVqWnp1B56QWel_nqZUUdwLu7nDVvt3a-ShQ=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzE3MCM2NjgwNTY5IzIxODA3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDgwMGJmOWMtNWQzYS00MDgxLWI2YTgtNjQ4YzVkMGMxYjQyLTExOTIzMzY=\/tiny\/Holzer-Holzer.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, Jan. 06, 2025 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Revance Therapeutics, Inc. (\u201cRevance\u201d or the \u201cCompany\u201d) (NASDAQ: RVNC). The lawsuit alleges that Defendants made materially false and\/or misleading statements, and\/or failed to disclose material adverse facts about Revance\u2019s business, operations, and prospects, including allegations that: (i) Revance was in material breach of its distribution agreement with Teoxane SA; (ii) the foregoing subjected Revance to an increased risk of litigation, as well as monetary and reputational harm; and (iii) all the foregoing increased the risk that Crown Laboratories, Inc.\u2019s tender offer to acquire all outstanding shares of the Company\u2019s common stock would be delayed and\/or amended. If you bought shares of Revance between February &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-798092","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, Jan. 06, 2025 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Revance Therapeutics, Inc. (\u201cRevance\u201d or the \u201cCompany\u201d) (NASDAQ: RVNC). The lawsuit alleges that Defendants made materially false and\/or misleading statements, and\/or failed to disclose material adverse facts about Revance\u2019s business, operations, and prospects, including allegations that: (i) Revance was in material breach of its distribution agreement with Teoxane SA; (ii) the foregoing subjected Revance to an increased risk of litigation, as well as monetary and reputational harm; and (iii) all the foregoing increased the risk that Crown Laboratories, Inc.\u2019s tender offer to acquire all outstanding shares of the Company\u2019s common stock would be delayed and\/or amended. If you bought shares of Revance between February &hellip; Continue reading &quot;SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-06T16:42:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzE3MCM2NjgwNTY5IzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\",\"datePublished\":\"2025-01-06T16:42:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\\\/\"},\"wordCount\":331,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzE3MCM2NjgwNTY5IzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\\\/\",\"name\":\"SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzE3MCM2NjgwNTY5IzIxODA3Njc=\",\"datePublished\":\"2025-01-06T16:42:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzE3MCM2NjgwNTY5IzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMyNzE3MCM2NjgwNTY5IzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/","og_locale":"en_US","og_type":"article","og_title":"SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk","og_description":"ATLANTA, Jan. 06, 2025 (GLOBE NEWSWIRE) &#8212; A shareholder class action lawsuit has been filed against Revance Therapeutics, Inc. (\u201cRevance\u201d or the \u201cCompany\u201d) (NASDAQ: RVNC). The lawsuit alleges that Defendants made materially false and\/or misleading statements, and\/or failed to disclose material adverse facts about Revance\u2019s business, operations, and prospects, including allegations that: (i) Revance was in material breach of its distribution agreement with Teoxane SA; (ii) the foregoing subjected Revance to an increased risk of litigation, as well as monetary and reputational harm; and (iii) all the foregoing increased the risk that Crown Laboratories, Inc.\u2019s tender offer to acquire all outstanding shares of the Company\u2019s common stock would be delayed and\/or amended. If you bought shares of Revance between February &hellip; Continue reading \"SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/","og_site_name":"Market Newsdesk","article_published_time":"2025-01-06T16:42:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzE3MCM2NjgwNTY5IzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm","datePublished":"2025-01-06T16:42:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/"},"wordCount":331,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzE3MCM2NjgwNTY5IzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/","name":"SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzE3MCM2NjgwNTY5IzIxODA3Njc=","datePublished":"2025-01-06T16:42:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzE3MCM2NjgwNTY5IzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMyNzE3MCM2NjgwNTY5IzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholder-alert-class-action-lawsuit-filed-on-behalf-of-revance-therapeutics-inc-rvnc-investors-holzer-holzer-llc-encourages-investors-with-significant-losses-to-contact-the-fi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors \u2013 Holzer &amp; Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/798092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=798092"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/798092\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=798092"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=798092"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=798092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}